Derm-Biome Pharmaceuticals Inc. sucht Kooperationspartner, um einen vielversprechenden Antitumorwirkstoff gegen Hautkrebs bei Hunden, Katzen und Pferden zu testen.
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_empty_space][vc_column_text] March 20, 2019 VANCOUVER, British Columbia — Derm-Biome Pharmaceuticals Inc, a Vancouver based start-up biopharmaceutical company, will be reaching out to the world’s top veterinary researchers and veterinary schools for collaborative opportunities to show efficacy of its lead compound NVX-207, in the underserved area of cancers in […]